Literature DB >> 10528086

Factors affecting the size distribution of liposomes produced by freeze-thaw extrusion.

J D Castile1, K M Taylor.   

Abstract

This paper describes the development of a protocol for the production of liposomes using a freeze-thaw extrusion methodology. Laser diffraction particle size analysis showed that the median diameter of freeze-thawed egg phosphatidylcholine multilamellar vesicles (eggPC MLVs) was increased when cholesterol was included in the bilayers. Using a freeze-thaw cycle of 3 min freezing in liquid nitrogen at -196 degrees C followed by 3 min thawing at 50 degrees C resulted in an anomalously large particle size for eggPC/cholesterol formulations. When liposomes were repeatedly freeze-thawed a maximum size was achieved after five freeze-thaw cycles. Dispersion of liposomes in sodium chloride solutions promoted size increases following freeze-thawing, suggesting that vesicles had aggregated or fused. Poloxamers P338 and P407 inhibited the size increases observed during freeze-thawing for eggPC MLVs dispersed in 1.0 M NaCl, probably through steric prevention of aggregation and fusion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528086     DOI: 10.1016/s0378-5173(99)00207-0

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  34 in total

1.  Protein encapsulation in unilamellar liposomes: high encapsulation efficiency and a novel technique to assess lipid-protein interaction.

Authors:  Xiaoming Xu; Antonio Costa; Diane J Burgess
Journal:  Pharm Res       Date:  2012-03-09       Impact factor: 4.200

2.  Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer.

Authors:  Mohanambe Lingappa; Hong Song; Sarah Thompson; Frank Bruchertseifer; Alfred Morgenstern; George Sgouros
Journal:  Cancer Res       Date:  2010-07-22       Impact factor: 12.701

Review 3.  A review of poloxamer 407 pharmaceutical and pharmacological characteristics.

Authors:  Gilles Dumortier; Jean Louis Grossiord; Florence Agnely; Jean Claude Chaumeil
Journal:  Pharm Res       Date:  2006-11-11       Impact factor: 4.200

4.  Freeze-anneal-thaw cycling of unilamellar liposomes: effect on encapsulation efficiency.

Authors:  Antonio P Costa; Xiaoming Xu; Diane J Burgess
Journal:  Pharm Res       Date:  2013-07-24       Impact factor: 4.200

5.  Size-induced enhancement of chemical exchange saturation transfer (CEST) contrast in liposomes.

Authors:  Jason M Zhao; Yah-el Har-el; Michael T McMahon; Jinyuan Zhou; A Dean Sherry; George Sgouros; Jeff W M Bulte; Peter C M van Zijl
Journal:  J Am Chem Soc       Date:  2008-03-25       Impact factor: 15.419

6.  Optimization of RGD-modified Nano-liposomes Encapsulating Eptifibatide.

Authors:  Hassan Bardania; Seyed Abbas Shojaosadati; Farzad Kobarfard; Farid Dorkoosh
Journal:  Iran J Biotechnol       Date:  2016-06       Impact factor: 1.671

7.  The Molecular Switching Mechanism at the Conserved D(E)RY Motif in Class-A GPCRs.

Authors:  Angelica Sandoval; Stefanie Eichler; Sineej Madathil; Philip J Reeves; Karim Fahmy; Rainer A Böckmann
Journal:  Biophys J       Date:  2016-07-12       Impact factor: 4.033

8.  Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.

Authors:  Mikhail A Zhukovsky; Stéphane Basmaciogullari; Beatriz Pacheco; Liping Wang; Navid Madani; Hillel Haim; Joseph Sodroski
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

9.  Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer.

Authors:  Stavroula Sofou; Richard Enmon; Stig Palm; Barry Kappel; Pat Zanzonico; Michael R McDevitt; David A Scheinberg; George Sgouros
Journal:  J Liposome Res       Date:  2010-01-13       Impact factor: 3.648

10.  Effects of sample handling and storage on quantitative lipid analysis in human serum.

Authors:  Angela M Zivkovic; Michelle M Wiest; Uyen Thao Nguyen; Ryan Davis; Steven M Watkins; J Bruce German
Journal:  Metabolomics       Date:  2009-08-05       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.